We are unable to draw your results. We are being notified of the problem, and we will address it as soon as possible. Thank you for your understanding.
Sending details to the GeneMANIA team...
Sent details to the GeneMANIA team
Could not send details to the GeneMANIA team; please send an email to the GeneMANIA team detailing your query
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Wang et al. (2006). Cancer Res.
Source: Pearson correlation with 231,830 interactions from GEO
Tags:
Multiclass cancer diagnosis using tumor gene expression signatures. Ramaswamy et al. (2001). Proc Natl Acad Sci U S A.
Source: Pearson correlation with 226,615 interactions from supplementary material
Tags:
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Radtke et al. (2009). Proc Natl Acad Sci U S A.
Source: Pearson correlation with 377,767 interactions from GEO
Tags:
Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. Gobble et al. (2011). Cancer Res.
Source: Pearson correlation with 449,507 interactions from GEO
Tags:
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Kang et al. (2010). Blood.
Source: Pearson correlation with 549,783 interactions from GEO
Tags:
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. Hummel et al. (2006). N Engl J Med.
Source: Pearson correlation with 466,765 interactions from GEO
Tags:
Gene signatures of progression and metastasis in renal cell cancer. Jones et al. (2005). Clin Cancer Res.
Source: Pearson correlation with 365,428 interactions from GEO
Tags:
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Bild et al. (2006). Nature.
Note: One of 3 datasets produced from this publication.
Source: Pearson correlation with 254,105 interactions from GEO
Tags:
Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Noble et al. (2008). Gut.
Source: Pearson correlation with 603,016 interactions from GEO
The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle. Wu et al. (2007). Endocrine.
Source: Pearson correlation with 223,988 interactions from GEO
Tags:
Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Nakayama et al. (2007). Mod Pathol.
Source: Pearson correlation with 361,398 interactions from GEO
Tags:
Tumor cell gene expression changes following short-term in vivo exposure to single agent chemotherapeutics are related to survival in multiple myeloma. Burington et al. (2008). Clin Cancer Res.
Source: Pearson correlation with 266,464 interactions from GEO
Tags:
Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. Burczynski et al. (2006). J Mol Diagn.
Source: Pearson correlation with 419,356 interactions from GEO
Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. Raue et al. (2012). J Appl Physiol.
Source: Pearson correlation with 483,849 interactions from GEO
Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Rieger et al. (2004). Proc Natl Acad Sci U S A.
Source: Pearson correlation with 220,846 interactions from GEO
Tags:
Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment. Arijs et al. (2009). PLoS One.
Source: Pearson correlation with 570,210 interactions from GEO
Tags:
Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. Peng et al. (2009). BMC Genomics.
Source: Pearson correlation with 349,954 interactions from GEO
Tags:
Gene expression changes in the course of normal brain aging are sexually dimorphic. Berchtold et al. (2008). Proc Natl Acad Sci U S A.
Source: Pearson correlation with 507,933 interactions from GEO
Tags:
Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis. Toedter et al. (2011). Am J Gastroenterol.
Source: Pearson correlation with 572,082 interactions from GEO
Tags:
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Perou et al. (1999). Proc Natl Acad Sci U S A.
Source: Pearson correlation with 50,804 interactions from supplementary material
Tags:
Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Johnson et al. (2003). Science.
Source: Pearson correlation with 426,934 interactions from GEO
Tags:
A comprehensive transcript index of the human genome generated using microarrays and computational approaches. Schadt et al. (2004). Genome Biol.
Note: Predicted transcript array
Source: Pearson correlation with 60,454 interactions from GEO
Source: Direct interaction with 171 interactions from iRefIndex
Source: Direct interaction with 345 interactions from BioGRID
A human functional protein interaction network and its application to cancer data analysis. Wu et al. (2010). Genome Biol.
Source: 78,448 interactions from supplementary material
Tags:
Source: Direct interaction with 24,924 interactions from Pathway Commons
Source: Direct interaction with 937 interactions from Pathway Commons
Source: Direct interaction with 10,118 interactions from Pathway Commons
Source: Direct interaction with 598 interactions from Pathway Commons
Source: Direct interaction with 685 interactions from Pathway Commons
Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes. Behzadnia et al. (2007). EMBO J.
Source: Direct interaction with 101 interactions from iRefIndex
Interaction and assembly of murine pre-replicative complex proteins in yeast and mouse cells. Kneissl et al. (2003). J Mol Biol.
Source: Direct interaction with 83 interactions from iRefIndex
Tags:
Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. McFarland et al. (2008). Mol Cell Proteomics.
Source: Direct interaction with 152 interactions from iRefIndex
Tags:
Systematic analysis of human protein complexes identifies chromosome segregation proteins. Hutchins et al. (2010). Science.
Source: Direct interaction with 141 interactions from iRefIndex
Tags:
Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Jeronimo et al. (2007). Mol Cell.
Source: Direct interaction with 660 interactions from iRefIndex
Tags:
Self-assembling protein microarrays. Ramachandran et al. (2004). Science.
Source: Direct interaction with 119 interactions from iRefIndex
A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Goudreault et al. (2009). Mol Cell Proteomics.
Source: Direct interaction with 242 interactions from iRefIndex
Tags:
A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Sato et al. (2004). Mol Cell.
Source: Direct interaction with 235 interactions from iRefIndex
Tags:
Large-scale structural analysis of the classical human protein tyrosine phosphatome. Barr et al. (2009). Cell.
Source: Direct interaction with 177 interactions from iRefIndex
Source: Direct interaction with 385 interactions from iRefIndex
A quantitative protein interaction network for the ErbB receptors using protein microarrays. Jones et al. (2006). Nature.
Source: Direct interaction with 139 interactions from iRefIndex
Tags:
Defining the human deubiquitinating enzyme interaction landscape. Sowa et al. (2009). Cell.
Note: One of 2 datasets produced from this publication.
Source: Direct interaction with 1,511 interactions from BioGRID
Source: Direct interaction with 41,955 interactions from iRefIndex
Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. Cannavo et al. (2007). J Biol Chem.
Source: Direct interaction with 109 interactions from iRefIndex
Tags:
Source: Direct interaction with 28,821 interactions from BioGRID
Source: Direct interaction with 12,700 interactions from iRefIndex
Source: Direct interaction with 5,310 interactions from iRefIndex
Source: Direct interaction with 637 interactions from iRefIndex
Source: Direct interaction with 21,448 interactions from iRefIndex
RNA and RNA binding proteins participate in early stages of cell spreading through spreading initiation centers. de Hoog et al. (2004). Cell.
Source: Direct interaction with 220 interactions from iRefIndex
Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Svendsen et al. (2009). Cell.
Source: Direct interaction with 233 interactions from iRefIndex
Tags:
Source: Direct interaction with 13,341 interactions from iRefIndex
An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Glatter et al. (2009). Mol Syst Biol.
Source: Direct interaction with 307 interactions from iRefIndex
Tags:
High-throughput mapping of a dynamic signaling network in mammalian cells. Barrios-Rodiles et al. (2005). Science.
Source: Direct interaction with 547 interactions from iRefIndex
Tags:
Mouse Piwi interactome identifies binding mechanism of Tdrkh Tudor domain to arginine methylated Miwi. Chen et al. (2009). Proc Natl Acad Sci U S A.
Note: I2D predictions of protein protein interactions using Chen-Pawson-2009 Mus musculus data
Source: Direct interaction with 30 interactions from I2D
A map of the interactome network of the metazoan C. elegans. Li et al. (2004). Science.
Note: I2D predictions of protein protein interactions using Li-Vidal-2004 Caenorhabditis elegans data
Source: Direct interaction with 567 interactions from I2D
BioGRID: a general repository for interaction datasets. Stark et al. (2006). Nucleic Acids Res.
Note: I2D predictions of protein protein interactions using BioGRID Saccharomyces cerevisiae data
Source: Direct interaction with 13,434 interactions from I2D
Comparative assessment of large-scale data sets of protein-protein interactions. von Mering et al. (2002). Nature.
Note: I2D predictions of protein protein interactions using vonMering-Bork-2002 Saccharomyces cerevisiae data
Source: Direct interaction with 1,196 interactions from I2D
A map of the interactome network of the metazoan C. elegans. Li et al. (2004). Science.
Note: I2D predictions of protein protein interactions using Li-Vidal-2004 Caenorhabditis elegans data
Source: Direct interaction with 15 interactions from I2D
Comparative assessment of large-scale data sets of protein-protein interactions. von Mering et al. (2002). Nature.
Note: I2D predictions of protein protein interactions using vonMering-Bork-2002 Saccharomyces cerevisiae data
Source: Direct interaction with 3,001 interactions from I2D
Comparative assessment of large-scale data sets of protein-protein interactions. von Mering et al. (2002). Nature.
Note: I2D predictions of protein protein interactions using vonMering-Bork-2002 Saccharomyces cerevisiae data
Source: Direct interaction with 16,074 interactions from I2D
A gene-coexpression network for global discovery of conserved genetic modules. Stuart et al. (2003). Science.
Source: 24,952 interactions from supplementary material
Tags:
High-quality binary protein interaction map of the yeast interactome network. Yu et al. (2008). Science.
Note: I2D predictions of protein protein interactions using Yu Gold Standard Saccharomyces cerevisiae data
Source: Direct interaction with 386 interactions from I2D
Tags:
The IntAct molecular interaction database in 2010. Aranda et al. (2010). Nucleic Acids Res.
Note: I2D predictions of protein protein interactions using IntAct Rattus norvegicus data
Source: Direct interaction with 1,054 interactions from I2D
MINT: a Molecular INTeraction database. Zanzoni et al. (2002). FEBS Lett.
Note: I2D predictions of protein protein interactions using MINT Mus musculus data
Source: Direct interaction with 977 interactions from I2D
MINT: a Molecular INTeraction database. Zanzoni et al. (2002). FEBS Lett.
Note: I2D predictions of protein protein interactions using MINT Rattus norvegicus data
Source: Direct interaction with 574 interactions from I2D
The IntAct molecular interaction database in 2010. Aranda et al. (2010). Nucleic Acids Res.
Note: I2D predictions of protein protein interactions using IntAct Mus musculus data
Source: Direct interaction with 3,422 interactions from I2D
BioGRID: a general repository for interaction datasets. Stark et al. (2006). Nucleic Acids Res.
Note: I2D predictions of protein protein interactions using BioGRID Mus musculus data
Source: Direct interaction with 288 interactions from I2D
Ontological visualization of protein-protein interactions. Drabkin et al. (2005). BMC Bioinformatics.
Note: I2D predictions of protein protein interactions using MGI Mus musculus data
Source: Direct interaction with 724 interactions from I2D
A map of the interactome network of the metazoan C. elegans. Li et al. (2004). Science.
Note: I2D predictions of protein protein interactions using Li-Vidal-2004 Caenorhabditis elegans data
Source: Direct interaction with 103 interactions from I2D
The IntAct molecular interaction database in 2010. Aranda et al. (2010). Nucleic Acids Res.
Note: I2D predictions of protein protein interactions using IntAct Drosophila melanogaster data
Source: Direct interaction with 3,920 interactions from I2D
BIND--a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bader et al. (2000). Bioinformatics.
Note: I2D predictions of protein protein interactions using BIND Rattus norvegicus data
Source: Direct interaction with 556 interactions from I2D
Systematic interactome mapping and genetic perturbation analysis of a C. elegans TGF-beta signaling network. Tewari et al. (2004). Mol Cell.
Note: I2D predictions of protein protein interactions usingTewari-Vidal-2004 Caenorhabditis elegans data
Source: Direct interaction with 18 interactions from I2D
Tags:
BIND--a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bader et al. (2000). Bioinformatics.
Note: I2D predictions of protein protein interactions using BIND Saccharomyces cerevisiae data
Source: Direct interaction with 1,543 interactions from I2D
MINT: a Molecular INTeraction database. Zanzoni et al. (2002). FEBS Lett.
Note: I2D predictions of protein protein interactions using MINT Caenorhabditis elegans data
Source: Direct interaction with 1,166 interactions from I2D
InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Lynn et al. (2008). Mol Syst Biol.
Note: I2D predictions of protein protein interactions using INNATEDB Mus musculus data
Source: Direct interaction with 1,455 interactions from I2D
Tags:
BIND--a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bader et al. (2000). Bioinformatics.
Note: I2D predictions of protein protein interactions using BIND Caenorhabditis elegans data
Source: Direct interaction with 911 interactions from I2D
An in vivo map of the yeast protein interactome. Tarassov et al. (2008). Science.
Note: I2D predictions of protein protein interactions using Tarassov-Michnick-2008 Saccharomyces cerevisiae data
Source: Direct interaction with 441 interactions from I2D
Tags:
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Krogan et al. (2006). Nature.
Note: I2D predictions of protein protein interactions using Krogan-Greenblatt-2006 Saccharomyces cerevisiae data
Source: Direct interaction with 1,794 interactions from I2D
BIND--a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. Bader et al. (2000). Bioinformatics.
Note: I2D predictions of protein protein interactions using BIND Mus musculus data
Source: Direct interaction with 1,198 interactions from I2D
Source: Pearson correlation with 530,357 interactions from Pfam
Source: Pearson correlation with 488,822 interactions from InterPro
major histocompatibility complex, class I, C [Source:HGNC Symbol;Acc:4933]
Functions:
Synonyms: ENSG00000204525; ENSG00000206435; ENSG00000206452; ENSG00000225691; ENSG00000228299; ENSG00000233841; ENSG00000237022; ENSP00000365402; ENSP00000365412; ENSP00000372813; ENSP00000372819; ENSP00000372975; ENSP00000372979; ENSP00000379553; ENSP00000383195; ENSP00000383244; ENSP00000383245; ENSP00000388708; ENSP00000389248; ENSP00000390282; ENSP00000390851; ENSP00000390860; ENSP00000391250; ENSP00000393374; ENSP00000393458; ENSP00000397867; ENSP00000398169; ENSP00000400410; ENSP00000403541; ENSP00000403624; ENSP00000404526; ENSP00000407051; ENSP00000407431; ENSP00000407494; ENSP00000410214; ENSP00000410579; ENSP00000410661; ENSP00000411867; ENSP00000412426; ENSP00000413189; ENSP00000413992; ENSP00000414063; ENSP00000415025; ENSP00000431141; ENSP00000431347; ENSP00000433088; ENSP00000433409; ENSP00000433897; ENSP00000435957; ENSP00000436842; ENSP00000436915; ENSP00000440406; ENSP00000447743; ENSP00000448156; 3107; HLA-C; NP_001229971; NP_002108; XP_003403605; XP_003403606; XP_003403607; XP_003403608; XP_003403609; XP_003403610; XP_003403611; XP_003403612; XP_003403613; XP_003403614; XP_003403615; XP_003403616; XP_003403617; XP_003403618; XP_003403619; NM_001243042; NM_002117; XM_003403557; XM_003403558; XM_003403559; XM_003403560; XM_003403561; XM_003403562; XM_003403563; XM_003403564; XM_003403565; XM_003403566; XM_003403567; XM_003403568; XM_003403569; XM_003403570; XM_003403571; D6S204; HLA-JY3; HLC-C; PSORS1; 1C01_HUMAN; 1C02_HUMAN; 1C03_HUMAN; 1C04_HUMAN; 1C05_HUMAN; 1C06_HUMAN; 1C07_HUMAN; 1C08_HUMAN; 1C12_HUMAN; 1C14_HUMAN; 1C15_HUMAN; 1C16_HUMAN; 1C17_HUMAN; 1C18_HUMAN; P04222; P10321; P30499; P30501; P30504; P30505; P30508; P30510; Q07000; Q29865; Q29960; Q29963; Q95604; Q9TNN7;
More at Entrez
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 [Source:HGNC Symbol;Acc:6329]
Functions:
Synonyms: ENSG00000125498; ENSP00000291633; ENSP00000336769; 3802; 3806; KIR2DL1; NP_055033; NP_055327; NM_014218; NM_014512; 47.11; CD158A; CD158H; cl-42; KIR-K64; KIR221; KIR2DS1; NKAT1; p50.1; p58.1; KI2L1_HUMAN; KI2S1_HUMAN; P43626; Q14954;
More at Entrez
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 [Source:HGNC Symbol;Acc:6331]
Functions:
Synonyms: ENSG00000243772; ENSP00000342215; ENSP00000415758; 100132285; 100653050; 3804; KIR2DL3; NP_036444; NP_056952; XP_003403456; XP_003403457; XP_003403458; XP_003403459; XP_003403460; XP_003403461; XP_003403462; XP_003403463; NM_012312; NM_014511; NM_015868; XM_003403408; XM_003403409; XM_003403410; XM_003403411; XM_003403412; XM_003403413; XM_003403414; XM_003403415; 183ActI; CD158B2; CD158J; cl-49; GL183; KIR-023GB; KIR-K7b; KIR-K7c; KIR2DS2; KIRCL23; LOC100653050; NKAT2; NKAT2A; NKAT2B; NKAT5; KI2L3_HUMAN; KI2S2_HUMAN; P43628; P43631;
More at Entrez
CD160 molecule [Source:HGNC Symbol;Acc:17013]
Functions:
Synonyms: ENSG00000117281; ENSP00000235933; ENSP00000358294; ENSP00000358296; ENSP00000385199; 11126; CD160; NP_008984; NM_007053; BY55; NK28; BY55_HUMAN; O95971;
More at Entrez
beta-2-microglobulin [Source:HGNC Symbol;Acc:914]
Functions:
Synonyms: ENSG00000166710; ENSP00000340858; ENSP00000379978; ENSP00000437604; ENSP00000452780; ENSP00000452861; ENSP00000453023; ENSP00000453186; ENSP00000453191; ENSP00000453350; 567; B2M; NP_004039; NM_004048; B2MG_HUMAN; P61769;
More at Entrez
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B [Source:HGNC Symbol;Acc:16346]
Functions:
Synonyms: ENSG00000215764; ENSP00000343498; ENSP00000375611; ENSP00000383644; ENSP00000383645; ENSP00000383646; ENSP00000383649; ENSP00000383650; ENSP00000383651; ENSP00000383652; ENSP00000383672; 100133046; 3803; 3813; 553128; 57292; KIR2DL5B; NP_001018091; NP_001077008; NP_055034; NP_065396; XP_003119153; XP_003403449; XP_003403623; XP_003403624; NM_001018081; NM_001083539; NM_014219; NM_020535; XM_003119105; XM_003403401; XM_003403575; XM_003403576; CD158B1; CD158F; KIR-123FM; KIR-G1; KIR2DL2; KIR2DL5; KIR2DL5.1; KIR2DL5.2; KIR2DL5.3; KIR2DL5.4; KIR2DL5A; KIR2DLX; KIR3DS1; NKAT10; NKAT6; p58.2; KI2L2_HUMAN; KI2LA_HUMAN; KI2LB_HUMAN; KI3S1_HUMAN; P43627; Q14943; Q8N109; Q8NHK3;
More at Entrez
major histocompatibility complex, class I, B [Source:HGNC Symbol;Acc:4932]
Functions:
Synonyms: ENSG00000206450; ENSG00000223532; ENSG00000224608; ENSG00000228964; ENSG00000232126; ENSG00000234745; ENSP00000352656; ENSP00000388208; ENSP00000392099; ENSP00000392235; ENSP00000392626; ENSP00000396397; ENSP00000396980; ENSP00000398100; ENSP00000399168; ENSP00000399675; ENSP00000400842; ENSP00000401183; ENSP00000401443; ENSP00000403471; ENSP00000405178; ENSP00000405365; ENSP00000405931; ENSP00000411954; ENSP00000416672; ENSP00000433363; ENSP00000435083; ENSP00000435221; ENSP00000435817; ENSP00000436637; ENSP00000446558; ENSP00000447662; ENSP00000449246; 3106; HLA-B; NP_005505; NM_005514; HLAB; SPDA1; 1B07_HUMAN; 1B08_HUMAN; 1B13_HUMAN; 1B14_HUMAN; 1B15_HUMAN; 1B18_HUMAN; 1B27_HUMAN; 1B35_HUMAN; 1B37_HUMAN; 1B38_HUMAN; 1B39_HUMAN; 1B40_HUMAN; 1B41_HUMAN; 1B42_HUMAN; 1B44_HUMAN; 1B45_HUMAN; 1B46_HUMAN; 1B47_HUMAN; 1B48_HUMAN; 1B49_HUMAN; 1B50_HUMAN; 1B51_HUMAN; 1B52_HUMAN; 1B53_HUMAN; 1B54_HUMAN; 1B55_HUMAN; 1B56_HUMAN; 1B57_HUMAN; 1B58_HUMAN; 1B59_HUMAN; 1B67_HUMAN; 1B73_HUMAN; 1B78_HUMAN; 1B81_HUMAN; 1B82_HUMAN; P01889; P03989; P10319; P18463; P18464; P18465; P30460; P30461; P30462; P30464; P30466; P30475; P30479; P30480; P30481; P30483; P30484; P30485; P30486; P30487; P30488; P30490; P30491; P30492; P30493; P30495; P30498; P30685; Q04826; Q29718; Q29836; Q29940; Q31610; Q31612; Q95365;
More at Entrez
major histocompatibility complex, class I, A [Source:HGNC Symbol;Acc:4931]
Functions:
Synonyms: ENSG00000206503; ENSG00000206505; ENSG00000223980; ENSG00000224320; ENSG00000227715; ENSG00000229215; ENSG00000231834; ENSG00000235657; ENSP00000348012; ENSP00000365998; ENSP00000366002; ENSP00000366005; ENSP00000366018; ENSP00000373100; ENSP00000373114; ENSP00000379873; ENSP00000388526; ENSP00000388724; ENSP00000390225; ENSP00000391738; ENSP00000392547; ENSP00000394582; ENSP00000394889; ENSP00000397962; ENSP00000398188; ENSP00000403575; ENSP00000403922; ENSP00000404678; ENSP00000406366; ENSP00000408986; ENSP00000410645; ENSP00000416233; ENSP00000432736; ENSP00000440033; ENSP00000446814; ENSP00000447614; ENSP00000447635; ENSP00000447962; ENSP00000447990; ENSP00000448077; ENSP00000448239; ENSP00000448516; ENSP00000448887; ENSP00000448992; ENSP00000449453; ENSP00000450169; ENSP00000450284; ENSP00000450314; 3105; HLA-A; NP_001229687; NP_002107; NM_001242758; NM_002116; HLAA; 1A01_HUMAN; 1A02_HUMAN; 1A03_HUMAN; 1A11_HUMAN; 1A23_HUMAN; 1A24_HUMAN; 1A25_HUMAN; 1A26_HUMAN; 1A29_HUMAN; 1A30_HUMAN; 1A31_HUMAN; 1A32_HUMAN; 1A33_HUMAN; 1A34_HUMAN; 1A36_HUMAN; 1A43_HUMAN; 1A66_HUMAN; 1A68_HUMAN; 1A69_HUMAN; 1A74_HUMAN; 1A80_HUMAN; P01891; P01892; P04439; P05534; P10314; P10316; P13746; P16188; P16189; P16190; P18462; P30443; P30447; P30450; P30453; P30455; P30456; P30457; P30459; P30512; Q09160;
More at Entrez
major histocompatibility complex, class I, G [Source:HGNC Symbol;Acc:4964]
Functions:
Synonyms: ENSG00000204632; ENSG00000206506; ENSG00000230413; ENSG00000233095; ENSG00000235346; ENSG00000235680; ENSG00000237216; ENSP00000353472; ENSP00000366011; ENSP00000366014; ENSP00000366024; ENSP00000373116; ENSP00000373117; ENSP00000373118; ENSP00000383506; ENSP00000383521; ENSP00000387624; ENSP00000388176; ENSP00000389522; ENSP00000389969; ENSP00000390678; ENSP00000392075; ENSP00000392347; ENSP00000396594; ENSP00000397331; ENSP00000397733; ENSP00000398200; ENSP00000401326; ENSP00000405238; ENSP00000408461; ENSP00000408773; ENSP00000409132; ENSP00000410247; ENSP00000412927; ENSP00000413926; ENSP00000415905; ENSP00000416408; ENSP00000432220; ENSP00000432239; ENSP00000433426; ENSP00000434622; ENSP00000436375; ENSP00000437036; ENSP00000447762; ENSP00000447780; ENSP00000448085; ENSP00000448363; ENSP00000449291; ENSP00000449903; 3135; HLA-G; NP_002118; NM_002127; MHC-G; HLAG_HUMAN; P17693;
More at Entrez
major histocompatibility complex, class I, F [Source:HGNC Symbol;Acc:4963]
Functions:
Synonyms: ENSG00000137403; ENSG00000204642; ENSG00000206509; ENSG00000229698; ENSG00000234487; ENSG00000235220; ENSG00000237508; ENSP00000259951; ENSP00000334263; ENSP00000345828; ENSP00000351977; ENSP00000366040; ENSP00000366044; ENSP00000366057; ENSP00000373007; ENSP00000373008; ENSP00000373121; ENSP00000373123; ENSP00000382201; ENSP00000387786; ENSP00000388133; ENSP00000389555; ENSP00000389590; ENSP00000390887; ENSP00000392251; ENSP00000393535; ENSP00000395853; ENSP00000396776; ENSP00000397376; ENSP00000397705; ENSP00000398913; ENSP00000399043; ENSP00000399120; ENSP00000399835; ENSP00000400112; ENSP00000400299; ENSP00000402853; ENSP00000404130; ENSP00000404395; ENSP00000405190; ENSP00000405198; ENSP00000407836; ENSP00000408540; ENSP00000409934; ENSP00000412140; ENSP00000414318; ENSP00000414500; ENSP00000414905; ENSP00000415017; ENSP00000415312; ENSP00000415401; ENSP00000416426; ENSP00000416998; ENSP00000446505; ENSP00000446526; ENSP00000446947; ENSP00000447078; ENSP00000447195; ENSP00000447228; ENSP00000447401; ENSP00000448096; ENSP00000448113; ENSP00000448260; ENSP00000448638; ENSP00000449164; ENSP00000449390; ENSP00000450053; ENSP00000450111; ENSP00000450119; ENSP00000450148; ENSP00000450176; ENSP00000450179; ENSP00000450300; ENSP00000450301; 3134; HLA-F; NP_001091948; NP_001091949; NP_061823; NM_001098478; NM_001098479; NM_018950; CDA12; HLA-5.4; HLA-CDA12; HLAF; HLAF_HUMAN; P30511;
More at Entrez
TYRO protein tyrosine kinase binding protein [Source:HGNC Symbol;Acc:12449]
Functions:
Synonyms: ENSG00000011600; ENSP00000262629; ENSP00000402371; ENSP00000445332; 7305; TYROBP; NP_001166985; NP_001166986; NP_003323; NP_937758; NM_001173514; NM_001173515; NM_003332; NM_198125; NR_033390; DAP12; KARAP; PLO-SL; PLOSL; O43914; TYOBP_HUMAN;
More at Entrez
major histocompatibility complex, class I, E [Source:HGNC Symbol;Acc:4962]
Functions:
Synonyms: ENSG00000204592; ENSG00000206493; ENSG00000225201; ENSG00000229252; ENSG00000230254; ENSG00000233904; ENSG00000236632; ENSP00000365817; ENSP00000373091; ENSP00000390707; ENSP00000397420; ENSP00000400458; ENSP00000402694; ENSP00000409910; ENSP00000450038; 3133; HLA-E; NP_005507; NM_005516; EA1.2; EA2.1; HLA-6.2; MHC; QA1; HLAE_HUMAN; P13747;
More at Entrez
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) [Source:HGNC Symbol;Acc:43]
Functions:
Synonyms: ENSG00000168394; ENSG00000206297; ENSG00000224212; ENSG00000224748; ENSG00000226173; ENSG00000227816; ENSG00000230705; ENSG00000232367; ENSP00000346206; ENSP00000372722; ENSP00000401149; ENSP00000401919; ENSP00000402316; ENSP00000405356; ENSP00000412933; ENSP00000413080; ENSP00000415660; ENSP00000446544; ENSP00000448043; ENSP00000448316; ENSP00000449504; ENSP00000449721; ENSP00000450202; ENSP00000450367; 6890; TAP1; NP_000584; NM_000593; ABC17; ABCB2; D6S114E; PSF-1; RING4; TAP1*0102N; TAP1N; Q03518; TAP1_HUMAN;
More at Entrez
major histocompatibility complex, class II, DR beta 1 [Source:HGNC Symbol;Acc:4948]
Functions:
Synonyms: ENSG00000196126; ENSG00000206240; ENSG00000206306; ENSG00000228080; ENSG00000229074; ENSG00000236884; ENSP00000331343; ENSP00000353099; ENSP00000382378; ENSP00000392280; ENSP00000392880; ENSP00000403458; ENSP00000405960; ENSP00000408795; ENSP00000409322; ENSP00000412168; ENSP00000446833; ENSP00000447688; ENSP00000449259; ENSP00000450140; 100507709; 100507714; 3123; HLA-DRB1; NP_001230894; NP_002115; XP_003119307; XP_003119308; XP_003119309; XP_003119339; XP_003119340; XP_003119341; XP_003403897; XP_003403898; XP_003403899; XP_003403900; NM_001243965; NM_002124; XM_003119259; XM_003119260; XM_003119261; XM_003119291; XM_003119292; XM_003119293; XM_003403849; XM_003403850; XM_003403851; XM_003403852; DRw10; HLA-DR1B; LOC100507709; LOC100507714; SS1; 2B11_HUMAN; 2B13_HUMAN; 2B14_HUMAN; 2B17_HUMAN; 2B18_HUMAN; 2B19_HUMAN; 2B1A_HUMAN; 2B1B_HUMAN; 2B1C_HUMAN; 2B1D_HUMAN; 2B1E_HUMAN; 2B1F_HUMAN; 2B1G_HUMAN; P01911; P01912; P04229; P13760; P13761; P20039; Q29974; Q30134; Q30167; Q5Y7A7; Q95IE3; Q9GIY3; Q9TQE0;
More at Entrez
butyrophilin, subfamily 3, member A2 [Source:HGNC Symbol;Acc:1139]
Functions:
Synonyms: ENSG00000186470; ENSP00000348751; ENSP00000366937; ENSP00000380140; ENSP00000380152; ENSP00000432138; ENSP00000433749; ENSP00000433880; ENSP00000434102; ENSP00000435952; ENSP00000442687; ENSP00000442908; 11118; BTN3A2; NP_001184175; NP_001184176; NP_001184177; NP_001184178; NP_008978; NM_001197246; NM_001197247; NM_001197248; NM_001197249; NM_007047; BT3.2; BT3.3; BT3A2_HUMAN; P78410;
More at Entrez
proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) [Source:HGNC Symbol;Acc:9546]
Functions:
Synonyms: ENSG00000239836; ENSG00000240065; ENSG00000240118; ENSG00000240508; ENSG00000242711; ENSG00000243067; ENSG00000243594; ENSG00000243958; ENSP00000363993; ENSP00000372595; ENSP00000372721; ENSP00000378739; ENSP00000378742; ENSP00000382305; ENSP00000382313; ENSP00000382516; ENSP00000382528; ENSP00000389541; ENSP00000393744; ENSP00000394363; ENSP00000394773; ENSP00000396311; ENSP00000396813; ENSP00000398642; ENSP00000401221; ENSP00000401229; ENSP00000401624; ENSP00000403857; ENSP00000404847; ENSP00000406077; ENSP00000406380; ENSP00000406858; ENSP00000407233; ENSP00000407810; ENSP00000408178; ENSP00000408447; ENSP00000409785; ENSP00000409850; ENSP00000411561; ENSP00000412027; ENSP00000413194; ENSP00000447017; ENSP00000447831; ENSP00000449073; ENSP00000449400; ENSP00000449402; ENSP00000449675; ENSP00000450252; 5698; PSMB9; NP_002791; NM_002800; NM_148954; beta1i; LMP2; PSMB6i; RING12; P28065; PSB9_HUMAN;
More at Entrez
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
Functions:
Synonyms: 3809; KIR2DS4; NP_036446; NM_012314; CD158I; KIR1D; KIR412; KKA3; NKAT8; P43632; Q6H2G7;
More at Entrez
CD8a molecule [Source:HGNC Symbol;Acc:1706]
Functions:
Synonyms: ENSG00000153563; ENSP00000283635; ENSP00000321631; ENSP00000386559; ENSP00000387314; ENSP00000398868; ENSP00000406978; ENSP00000438371; 925; CD8A; NP_001139345; NP_001759; NP_741969; NM_001145873; NM_001768; NM_171827; NR_027353; CD8; CD8A_HUMAN; P01732;
More at Entrez
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) [Source:HGNC Symbol;Acc:9545]
Functions:
Synonyms: ENSG00000204264; ENSG00000206298; ENSG00000226201; ENSG00000230034; ENSG00000230669; ENSG00000231631; ENSG00000235715; ENSG00000236443; ENSP00000364015; ENSP00000364016; ENSP00000372723; ENSP00000372725; ENSP00000378748; ENSP00000382538; ENSP00000392693; ENSP00000394090; ENSP00000394155; ENSP00000396430; ENSP00000397057; ENSP00000401868; ENSP00000402406; ENSP00000404585; ENSP00000404615; ENSP00000406797; ENSP00000406878; ENSP00000406913; ENSP00000407539; ENSP00000408825; ENSP00000410205; ENSP00000412618; ENSP00000414731; ENSP00000414770; ENSP00000448520; 5696; PSMB8; NP_004150; NP_683720; NM_004159; NM_148919; beta5i; D6S216; D6S216E; JMP; LMP7; NKJO; PSMB5i; RING10; P28062; PSB8_HUMAN;
More at Entrez
major histocompatibility complex, class II, DR alpha [Source:HGNC Symbol;Acc:4947]
Functions:
Synonyms: ENSG00000204287; ENSG00000206308; ENSG00000226260; ENSG00000227993; ENSG00000228987; ENSG00000230726; ENSG00000234794; ENSP00000364121; ENSP00000372608; ENSP00000372745; ENSP00000372746; ENSP00000378786; ENSP00000392789; ENSP00000398838; ENSP00000402951; ENSP00000403385; ENSP00000404533; ENSP00000405295; ENSP00000410443; ENSP00000411610; ENSP00000412562; ENSP00000443327; ENSP00000446742; ENSP00000446750; ENSP00000446751; ENSP00000446911; ENSP00000447027; ENSP00000447052; ENSP00000447375; ENSP00000447577; ENSP00000447755; ENSP00000447849; ENSP00000448422; ENSP00000448765; ENSP00000449251; ENSP00000449599; ENSP00000450172; ENSP00000450200; 3122; HLA-DRA; NP_061984; NM_019111; HLA-DRA1; MLRW; DRA_HUMAN; P01903;
More at Entrez
| query genes | n/a | 1 / 1 |
| MHC class I receptor activity | 1.99E-16 | 8 / 19 |
| phagocytic vesicle membrane | 1.99E-16 | 8 / 18 |
| antigen processing and presentation | 1.99E-16 | 11 / 107 |
| antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.7E-16 | 10 / 71 |
| antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.78E-16 | 10 / 74 |
| antigen processing and presentation of exogenous peptide antigen | 3.78E-16 | 10 / 75 |
| antigen processing and presentation of exogenous antigen | 3.78E-16 | 10 / 75 |
| antigen processing and presentation of peptide antigen via MHC class I | 2.27E-15 | 10 / 90 |
| antigen processing and presentation of peptide antigen | 3.55E-15 | 10 / 95 |
| phagocytic vesicle | 1.09E-14 | 8 / 33 |
| ER to Golgi transport vesicle membrane | 5.01E-14 | 7 / 19 |
| interferon-gamma-mediated signaling pathway | 6.91E-14 | 9 / 77 |
| ER to Golgi transport vesicle | 9.77E-14 | 7 / 21 |
| cellular response to interferon-gamma | 1.2E-13 | 9 / 83 |
| response to interferon-gamma | 3.98E-13 | 9 / 95 |
| integral to lumenal side of endoplasmic reticulum membrane | 4.1E-13 | 6 / 11 |
| early endosome membrane | 5.69E-13 | 7 / 27 |
| endocytic vesicle membrane | 1.1E-12 | 8 / 60 |
| endosome membrane | 6.2E-12 | 9 / 131 |
| transport vesicle membrane | 6.82E-12 | 7 / 38 |
| endosomal part | 7.92E-12 | 9 / 136 |
| endocytic vesicle | 5.87E-11 | 8 / 99 |
| cytokine-mediated signaling pathway | 9.3E-11 | 10 / 282 |
| integral to endoplasmic reticulum membrane | 1.72E-10 | 7 / 60 |
| intrinsic to endoplasmic reticulum membrane | 1.86E-10 | 7 / 61 |
| type I interferon-mediated signaling pathway | 5.21E-10 | 7 / 71 |
| cellular response to type I interferon | 5.21E-10 | 7 / 71 |
| response to type I interferon | 5.57E-10 | 7 / 72 |
| coated vesicle membrane | 5.94E-10 | 7 / 73 |
| transport vesicle | 6.34E-10 | 7 / 74 |
| cytoplasmic vesicle membrane | 1.99E-9 | 8 / 159 |
| vesicle membrane | 2.47E-9 | 8 / 164 |
| early endosome | 5.81E-9 | 7 / 102 |
| integral to organelle membrane | 1.5E-8 | 7 / 117 |
| cytoplasmic vesicle part | 1.72E-8 | 8 / 211 |
| intrinsic to organelle membrane | 2.14E-8 | 7 / 124 |
| coated vesicle | 3.8E-8 | 7 / 135 |
| Golgi membrane | 4.1E-7 | 7 / 190 |
| antigen binding | 2.64E-3 | 3 / 32 |
| immune response-regulating cell surface receptor signaling pathway | 3.98E-3 | 4 / 122 |
| lymphocyte activation | 5.07E-3 | 5 / 283 |
| cellular defense response | 1.35E-2 | 3 / 56 |
| MHC class II receptor activity | 2.25E-2 | 2 / 10 |
| immune response-regulating signaling pathway | 2.94E-2 | 4 / 208 |
| T cell activation | 3.09E-2 | 4 / 212 |
| MHC class I protein binding | 3.65E-2 | 2 / 13 |
| immune effector process | 3.86E-2 | 4 / 227 |
| peptide antigen binding | 4.7E-2 | 2 / 15 |
| late endosome membrane | 5.95E-2 | 2 / 17 |
| positive regulation of immune response | 7.28E-2 | 4 / 272 |
| MHC protein binding | 8.81E-2 | 2 / 21 |
3.1.2
19 July 2012 20:00:00
server5.baderlab.med.utoronto.ca:80
server5.baderlab.med.utoronto.ca
192.168.81.45
20 June 2013 03:53:44
CCBot/2.0
192.168.81.45
50.16.166.175
/link
/WEB-INF/jsp/results.jsp
GET
4
3107
AUTOMATIC_SELECT
20
49F73769E7EF480B013BD565C42BD88C.genemania